(NASDAQ: MEDP) Medpace Holdings's forecast annual revenue growth rate of 14.65% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.
Medpace Holdings's revenue in 2024 is $1,885,842,000.On average, 3 Wall Street analysts forecast MEDP's revenue for 2024 to be $67,076,487,243, with the lowest MEDP revenue forecast at $66,823,707,472, and the highest MEDP revenue forecast at $67,270,547,547. On average, 3 Wall Street analysts forecast MEDP's revenue for 2025 to be $77,489,703,474, with the lowest MEDP revenue forecast at $76,667,507,893, and the highest MEDP revenue forecast at $78,811,429,778.
In 2026, MEDP is forecast to generate $87,269,463,071 in revenue, with the lowest revenue forecast at $86,229,030,391 and the highest revenue forecast at $88,309,895,751.